Atlas Trials

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

Clinical trial NCT02162264 · COMPLETED

Trial details

NCT number
NCT02162264
Sponsor
Eisai Co., Ltd.
Status
COMPLETED
Study type
OBSERVATIONAL
Alzheimer's Disease
Start date
2013-06-01
Primary completion
2015-05-30
Enrollment
8662

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.